Identification of novel genetic causes of Rett syndrome-like phenotypes
暂无分享,去创建一个
D. Pinto | G. Oliveira | A. Ameur | A. Syvänen | S. Sauer | U. Gyllensten | A. I. Dias | M. Barbosa | F. Lopes | P. Maciel | G. Soares | P. Cabral | J. P. Vieira | I. Jonasson | T. Temudo | Sofia Esteves | E. Calado | Joaquim de Sá | Isabel Fineza Cruz | Renata Oliveira
[1] Michael R. Johnson,et al. De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. , 2014, American journal of human genetics.
[2] Gigyf Fbxo. Monogenic Parkinson ' s disease and parkinsonism : Clinical phenotypes and frequencies of known mutations , 2017 .
[3] W. Kaufmann,et al. Mutations in epilepsy and intellectual disability genes in patients with features of Rett syndrome , 2015, American journal of medical genetics. Part A.
[4] T. Matsuishi,et al. De novo SHANK3 mutation causes Rett syndrome‐like phenotype in a female patient , 2015, American journal of medical genetics. Part A.
[5] R. Borgatti,et al. A de-novo STXBP1 gene mutation in a patient showing the Rett syndrome phenotype , 2015, Neuroreport.
[6] Ulf Gyllensten,et al. CanvasDB: a local database infrastructure for analysis of targeted- and whole genome re-sequencing projects , 2014, Database J. Biol. Databases Curation.
[7] Epilepsy Phenome,et al. De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. , 2014, American journal of human genetics.
[8] A. Hoischen,et al. A de novo non-sense mutation in ZBTB18 in a patient with features of the 1q43q44 microdeletion syndrome , 2013, European Journal of Human Genetics.
[9] Oksana Berezovska,et al. MeCP2: a novel Huntingtin interactor. , 2014, Human molecular genetics.
[10] S. Bardien,et al. EIF4G1 R1205H and VPS35 D620N mutations are rare in Parkinson's disease from South Africa , 2014, Neurobiology of Aging.
[11] J. Shendure,et al. A de novo convergence of autism genetics and molecular neuroscience , 2014, Trends in Neurosciences.
[12] Judith A. Blake,et al. The Mouse Genome Database: integration of and access to knowledge about the laboratory mouse , 2013, Nucleic Acids Res..
[13] Deanna M. Church,et al. ClinVar: public archive of relationships among sequence variation and human phenotype , 2013, Nucleic Acids Res..
[14] S. Holder,et al. Interstitial 3p25 deletion in a patient with features of 3p deletion syndrome: further evidence for the role of SRGAP3 in mental retardation. , 2014, Clinical dysmorphology.
[15] Y. Wada,et al. De Novo Mutations in SLC35A2 Encoding a UDP‐Galactose Transporter Cause Early‐Onset Epileptic Encephalopathy , 2013, Human mutation.
[16] Nancy Y. Villa,et al. Human Eukaryotic Initiation Factor 4G (eIF4G) Protein Binds to eIF3c, -d, and -e to Promote mRNA Recruitment to the Ribosome* , 2013, The Journal of Biological Chemistry.
[17] U. Muthane,et al. VPS35 and EIF4G1 mutations are rare in Parkinson's disease among Indians , 2013, Neurobiology of Aging.
[18] B. Peters,et al. Truncating mutations of MAGEL2cause Prader-Willi phenotypes and autism , 2013, Nature Genetics.
[19] P. Fergelot,et al. Expanding the clinical phenotype at the 3q13.31 locus with a new case of microdeletion and first characterization of the reciprocal duplication. , 2013, Molecular genetics and metabolism.
[20] M. Mehler,et al. Functions of Huntingtin in Germ Layer Specification and Organogenesis , 2013, PloS one.
[21] I. Scheffer,et al. Head stereotypies in STXBP1 encephalopathy , 2013, Developmental medicine and child neurology.
[22] M. Bayfield,et al. Conservation of RNA chaperone activity of the human La-related proteins 4, 6 and 7. , 2013 .
[23] K. Veeramah,et al. Exome sequencing reveals new causal mutations in children with epileptic encephalopathies , 2013, Epilepsia.
[24] Ludmila Kousoulidou,et al. 263.4 kb deletion within the TCF4 gene consistent with Pitt-Hopkins syndrome, inherited from a mosaic parent with normal phenotype. , 2013, European journal of medical genetics.
[25] Anna Gambin,et al. Application of custom-designed oligonucleotide array CGH in 145 patients with autistic spectrum disorders , 2012, European Journal of Human Genetics.
[26] K. Xia,et al. Analysis of EIF4G1 in ethnic Chinese , 2013, BMC Neurology.
[27] Emily H Turner,et al. Mosaicism of the UDP-galactose transporter SLC35A2 causes a congenital disorder of glycosylation. , 2013, American journal of human genetics.
[28] J. Deragon,et al. The association of a La module with the PABP-interacting motif PAM2 is a recurrent evolutionary process that led to the neofunctionalization of La-related proteins. , 2013, RNA.
[29] M. Farrer,et al. Sequence variants in eukaryotic translation initiation factor 4-gamma (eIF4G1) are associated with Lewy body dementia , 2013, Acta Neuropathologica.
[30] Bradley P. Coe,et al. Multiplex Targeted Sequencing Identifies Recurrently Mutated Genes in Autism Spectrum Disorders , 2012, Science.
[31] M. Forrest,et al. Functional analysis of TCF4 missense mutations that cause Pitt–Hopkins syndrome , 2012, Human mutation.
[32] R. Guerrini,et al. Epilepsy in Rett syndrome, and CDKL5‐ and FOXG1‐gene–related encephalopathies , 2012, Epilepsia.
[33] B. V. van Bon,et al. Diagnostic exome sequencing in persons with severe intellectual disability. , 2012, The New England journal of medicine.
[34] D. Horn,et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study , 2012, The Lancet.
[35] Kenny Q. Ye,et al. An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.
[36] Allan R. Jones,et al. An anatomically comprehensive atlas of the adult human brain transcriptome , 2012, Nature.
[37] S. Steinberg,et al. Rate of de novo mutations and the importance of father’s age to disease risk , 2012, Nature.
[38] Toshiro K. Ohsumi,et al. Sequencing Chromosomal Abnormalities Reveals Neurodevelopmental Loci that Confer Risk across Diagnostic Boundaries , 2012, Cell.
[39] M. Rudnicki,et al. Snf2l regulates Foxg1-dependent progenitor cell expansion in the developing brain. , 2012, Developmental cell.
[40] A. Bosserhoff,et al. Nucleosome Remodeler SNF2L Suppresses Cell Proliferation and Migration and Attenuates Wnt Signaling , 2012, Molecular and Cellular Biology.
[41] Evan T. Geller,et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders , 2012, Nature.
[42] Kara L Hamilton-Nelson,et al. Evidence of novel fine-scale structural variation at autism spectrum disorder candidate loci , 2012, Molecular Autism.
[43] Bradley P. Coe,et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations , 2012, Nature.
[44] Joseph K. Pickrell,et al. A Systematic Survey of Loss-of-Function Variants in Human Protein-Coding Genes , 2012, Science.
[45] F. Saudou,et al. Modification of Mecp2 dosage alters axonal transport through the Huntingtin/Hap1 pathway , 2012, Neurobiology of Disease.
[46] A. Afenjar,et al. Novel comprehensive diagnostic strategy in Pitt–Hopkins syndrome: Clinical score and further delineation of the TCF4 mutational spectrum , 2012, Human mutation.
[47] M. Avoli,et al. Genes in infantile epileptic encephalopathies -- Jasper's Basic Mechanisms of the Epilepsies , 2012 .
[48] Keiichi I. Nakayama,et al. Histone H1 Recruitment by CHD8 Is Essential for Suppression of the Wnt–β-Catenin Signaling Pathway , 2011, Molecular and Cellular Biology.
[49] Wei Chen,et al. Deep sequencing reveals 50 novel genes for recessive cognitive disorders , 2011, Nature.
[50] C. Depienne,et al. STXBP1‐related encephalopathy presenting as infantile spasms and generalized tremor in three patients , 2011, Epilepsia.
[51] C. Sander,et al. Predicting the functional impact of protein mutations: application to cancer genomics , 2011, Nucleic acids research.
[52] R. Pettinato,et al. The Pitt‐Hopkins syndrome: Report of 16 new patients and clinical diagnostic criteria , 2011, American journal of medical genetics. Part A.
[53] Kathryn Roeder,et al. Multiple Recurrent De Novo CNVs, Including Duplications of the 7q11.23 Williams Syndrome Region, Are Strongly Associated with Autism , 2011, Neuron.
[54] F. Alkuraya,et al. A TCTN2 mutation defines a novel Meckel Gruber syndrome locus , 2011, Human mutation.
[55] Matthew J. Brauer,et al. Mapping the NPHP-JBTS-MKS Protein Network Reveals Ciliopathy Disease Genes and Pathways , 2011, Cell.
[56] P. Thuras,et al. Deficits in GABAB receptor system in schizophrenia and mood disorders: A postmortem study , 2011, Schizophrenia Research.
[57] J. Lacaille,et al. Intellectual disability without epilepsy associated with STXBP1 disruption , 2011, European Journal of Human Genetics.
[58] A. Gonzalez-Perez,et al. Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. , 2011, American journal of human genetics.
[59] Helga Thorvaldsdóttir,et al. Integrative Genomics Viewer , 2011, Nature Biotechnology.
[60] J. Rosenfeld,et al. High-resolution array CGH defines critical regions and candidate genes for microcephaly, abnormalities of the corpus callosum, and seizure phenotypes in patients with microdeletions of 1q43q44 , 2011, Human Genetics.
[61] C. Depienne,et al. Genes in infantile epileptic encephalopathies , 2010 .
[62] W. Kaufmann,et al. Rett syndrome: Revised diagnostic criteria and nomenclature , 2010, Annals of neurology.
[63] Christian Gilissen,et al. A de novo paradigm for mental retardation , 2010, Nature Genetics.
[64] Serafim Batzoglou,et al. Identifying a High Fraction of the Human Genome to be under Selective Constraint Using GERP++ , 2010, PLoS Comput. Biol..
[65] G. Kozlov,et al. La-Related Protein 4 Binds Poly(A), Interacts with the Poly(A)-Binding Protein MLLE Domain via a Variant PAM2w Motif, and Can Promote mRNA Stability , 2010, Molecular and Cellular Biology.
[66] I. Scheffer,et al. Clinical spectrum of early-onset epileptic encephalopathies associated with STXBP1 mutations , 2010, Neurology.
[67] Jana Marie Schwarz,et al. MutationTaster evaluates disease-causing potential of sequence alterations , 2010, Nature Methods.
[68] A. Valencia,et al. Mosaic uniparental disomies and aneuploidies as large structural variants of the human genome. , 2010, American journal of human genetics.
[69] Gary D. Bader,et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function , 2010, Nucleic Acids Res..
[70] Christian Gilissen,et al. De novo mutations of SETBP1 cause Schinzel-Giedion syndrome , 2010, Nature Genetics.
[71] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[72] J. Downing,et al. Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia. , 2010, Blood.
[73] K. Pollard,et al. Detection of nonneutral substitution rates on mammalian phylogenies. , 2010, Genome research.
[74] Vivian G. Cheung,et al. Genetic analysis of radiation-induced changes in human gene expression , 2009, Nature.
[75] Manuel Corpas,et al. DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. , 2009, American journal of human genetics.
[76] K. Hirschhorn,et al. Clinical Utility of Array CGH for the Detection of Chromosomal Imbalances Associated with Mental Retardation and Multiple Congenital Anomalies , 2009, Annals of the New York Academy of Sciences.
[77] P. Thuras,et al. Expression of GABAB Receptors Is Altered in Brains of Subjects with Autism , 2009, The Cerebellum.
[78] Sjoerd J. Vosse,et al. Across array comparative genomic hybridization: A strategy to reduce reference channel hybridizations , 2008, Genes, chromosomes & cancer.
[79] David Warde-Farley,et al. GeneMANIA: a real-time multiple association network integration algorithm for predicting gene function , 2008, Genome Biology.
[80] Naomichi Matsumoto,et al. De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy , 2008, Nature Genetics.
[81] A. Hartemink,et al. Computational and experimental identification of novel human imprinted genes. , 2007, Genome research.
[82] Joseph T. Glessner,et al. PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. , 2007, Genome research.
[83] C. Yau,et al. QuantiSNP: an Objective Bayes Hidden-Markov Model to detect and accurately map copy number variation using SNP genotyping data , 2007, Nucleic acids research.
[84] A. Federico,et al. The spectrum of mutations for the diagnosis of vanishing white matter disease , 2006, Neurological Sciences.
[85] W. Gerald,et al. Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number. , 2006, Cancer research.
[86] P. Sokoloff,et al. Linkage with the Ser9Gly DRD3 polymorphism in essential tremor families , 2006, Clinical Genetics.
[87] Modesto Orozco,et al. PMUT: a web-based tool for the annotation of pathological mutations on proteins , 2005, Bioinform..
[88] N. Kobayashi,et al. DBC2 significantly influences cell-cycle, apoptosis, cytoskeleton and membrane-trafficking pathways. , 2005, Journal of molecular biology.
[89] F. Speleman,et al. Rapid detection of VHL exon deletions using real-time quantitative PCR , 2005, Laboratory Investigation.
[90] J. Gécz,et al. Disruptions of the novel KIAA1202 gene are associated with X-linked mental retardation , 2005, Human Genetics.
[91] C. Carpenter,et al. RhoBTB2 is a substrate of the mammalian Cul3 ubiquitin ligase complex. , 2004, Genes & development.
[92] P. Stenson,et al. Human Gene Mutation Database (HGMD®): 2003 update , 2003, Human mutation.
[93] D. Bartsch,et al. The novel Rho-GTPase activating gene MEGAP/ srGAP3 has a putative role in severe mental retardation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[94] A. Fukui,et al. Nuclear Localization of Duplin, a β-Catenin-binding Protein, Is Essential for Its Inhibitory Activity on the Wnt Signaling Pathway* , 2002, The Journal of Biological Chemistry.
[95] B. Hagberg. Clinical manifestations and stages of Rett syndrome. , 2002, Mental retardation and developmental disabilities research reviews.
[96] S. Henikoff,et al. Predicting deleterious amino acid substitutions. , 2001, Genome research.
[97] C. Brannan,et al. Expression and imprinting of MAGEL2 suggest a role in Prader-willi syndrome and the homologous murine imprinting phenotype. , 2000, Human molecular genetics.
[98] E. Hawrot,et al. The metabotropic GABA receptor: molecular insights and their functional consequences , 2000, Cellular and Molecular Life Sciences CMLS.
[99] M. Gill,et al. European Multicentre Association Study of Schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms. , 1998, American journal of medical genetics.
[100] T. Gibson,et al. The SANT domain: a putative DNA-binding domain in the SWI-SNF and ADA complexes, the transcriptional co-repressor N-CoR and TFIIIB. , 1996, Trends in biochemical sciences.
[101] A. Joyner,et al. Inactivation of the mouse Huntington's disease gene homolog Hdh. , 1995, Science.
[102] R. Treisman,et al. The POZ domain: a conserved protein-protein interaction motif. , 1994, Genes & development.
[103] A. Reiss,et al. Neuroanatomy of Rett syndrome: A volumetric imaging study , 1993, Annals of neurology.
[104] V. Blinov,et al. Two related superfamilies of putative helicases involved in replication, recombination, repair and expression of DNA and RNA genomes. , 1989, Nucleic acids research.